Founders and Senior Management

Salvatore J. Salamone, Chief Executive Officer

Dr. Salamone has over 25 years experience in the health care and medical device industries. Prior to founding Saladax, Dr. Salamone was Vice President of Research and Development, Roche Diagnostics, where he was responsible for North American research and development efforts for the Laboratory Systems Division. Dr. Salamone's efforts during his 17-year tenure at Roche resulted in the launch of 7 major reagent product lines, comprised of over 70 FDA-approved products and more than 200 instrument applications. These products have generated in excess of $1 billion in cumulative revenue to date. Five of these product lines are based on nanoparticle technology similar to that utilized in the MyCare product line. Dr. Salamone is world-recognized in the field of drug monitoring with well over 100 publications, including textbook chapters, books, patents, and articles in the area. Dr. Salamone received 2 bachelor's degrees from Villanova University, a master's and a Ph.D. degree from Rutgers University, and was a SERC Post-Doctoral Fellow at Oxford University.

Adrienne Choma, President & Chief Operating Officer

Ms. Choma is a cofounder of Saladax and has over 25 years experience in the health care field. She began her 20-year career at Hoffmann-LaRoche as an attorney and joined the Diagnostic Division where she held titles of Director, Business Research & Planning; Vice President, New Product Development and Regulatory Affairs; Vice President, Operations; Vice President, International Drug Monitoring Business Unit; and Vice President, Marketing & Sales for the U.S. She worked closely with Dr. Salamone in the successful development and launch of 4 reagent product lines at Roche. Before founding Saladax, Ms. Choma served as Chief Operating Officer of Alfa Wassermann, Inc., with global responsibility for a division of this Italian pharmaceutical company dedicated to the diagnostic business. Ms. Choma earned her bachelor's degree from Rutgers University and her J.D. degree from New York University where she was a recipient of the Root-Tilden Scholarship.

Keith Galloway, Vice President of Marketing & Sales

Mr. Galloway is a seasoned Marketing and Sales executive with a long record of success in the diagnostic industry. Since 2001, he has been a senior executive with Varian, a global life sciences company where he has held positions of V.P. of Sales and Marketing and most recently as Business Manager and head of Global Sales and Marketing for Varian's diagnostics business. Executive experience also includes 11 years with Roche Diagnostics at the senior-most sales, strategic planning and marketing functions across multiple disciplines in the IVD market. He has also been awarded three U.S. patents, which to date have resulted in excess of $200M in sales. He has been an occasional guest lecturer in organizational management, market auditing, and sales force optimization at leading universities including Temple, Wharton, and LaSalle. Mr. Galloway has a master's degree from Lehigh University, and completed undergraduate work at Shippensburg University.

Gary Feiss, Vice President, Clinical Development & Regulatory Affairs.

Mr. Feiss has over twenty years' experience in healthcare, most recently serving as Director of Clinical Trials at Orasure Technologies, where he oversaw the clinical development and regulatory approval activities for the Hepatitis C Antibody rapid test and the OraQuick ADVANCE HIV 1/2 Antibody Test Over-the-Counter program. Prior to that, he served as Associate Vice President & Head of Clinical Development and Regulatory Affairs at Sanofi-Aventis, Vice President of Regulatory Affairs at Covalent Group, and held positions in Bioglan Pharma and Aventis Pharma (formerly Rhone-Poulenc Rorer). Over this tenure he has had significant contributions to the regulatory approvals of multiple new drugs and medical devices in the US and internationally.

Jodi Courtney, Director of R&D

Ms. Courtney spent 15 years in the Roche Diagnostics Research and Development Department, working with Dr. Salamone. She was instrumental in developing many of the technologies and procedures that were used in the successfully launched drug management product lines. While at Roche, Ms. Courtney developed her international experience working in Basel, Switzerland, where she was responsible for system integration of drug management products on the first medium-throughput consolidated Roche instrument. Ms. Courtney received her bachelor’s degree from Beloit College where she graduated first in her class of chemistry and attended Cornell University as a graduate student.

Toni L. Klich, Director of Finance and Administration

Ms. Klich has over 25 years of experience in the pharmaceutical industry and is responsible for all finance and administrative functions of the company. Prior to joining Saladax, she was with Enzon Pharmaceuticals, Inc., a biopharmaceutical company focused on the treatment of cancer and other life-threatening conditions. During her tenure, Ms. Klich held positions of increasing responsibility in the finance and accounting area, with her last position as the Company’s Controller/Director of Accounting. Ms. Klich received her bachelor’s degree in accounting from Rutgers University.